• P. Debyelaan 25

    6229 HX Maastricht

    Netherlands

Research Output

Filter
Conference Abstract/Poster in journal
2016

Durable suppression of disease activity by alemtuzumab in the absence of continuous treatment over 6 years in patients with active relapsing-remitting multiple sclerosis and an inadequate response to prior therapy (CARE-MS II)

LaGanke, C., De Seze, J., Freedman, M. S., Habek, M., Hupperts, R. M. M., Limmroth, V., Macdonell, R. A. L., Selmaj, K. W., Margolin, D. H., Thangavelu, K. & Havrdova, E., Sep 2016, In : Multiple Sclerosis Journal. 22, p. 327-328 2 p.

Research output: Contribution to journalConference Abstract/Poster in journalAcademic

IGM ANTI-MAG PERIPHERAL NEUROPATHY: FROM PROPER ASSESSMENT TO TRIAL NEEDS (IMAGINE STUDY)

Pruppers, M., Merkies, I. S. J., Faber, C. G., Lunn, M. P. T., Leger, J-M., Nobile-Orazio, E. & Notermans, N., Sep 2016, In : Journal of the Peripheral Nervous System. 21, 3, p. 202-202

Research output: Contribution to journalConference Abstract/Poster in journalAcademic